Day 5:
Studies Demonstrate Effectiveness of Exemestane in Early Stage Breast Cancer
Can HPV Vaccination Eradicate Cervical Cancer?
Targeting Soft-Tissue Sarcoma with Heat During Chemotherapy Improves Outcomes
On the Road to Personalizing Radiation Therapy
Researchers Propose Standard of Care for Patients with Partially Platinum-Sensitive Ovarian Cancer
Day 4:
PRIME Trial Offers More Good News for Panitumumab in Metastatic Colorectal Cancer
Progression-free Survival Significantly Improved in Breast Cancer Patients on Sorafenib
Novel TAK-1 Inhibitor Reduces Resistance of Pancreatic Cancer Cells to Chemotherapy
Questioning Cancer Research Priorities
ABCSG-24 Finds Neoadjuvant Capecitabine Improves Complete Response in Early Stage Breast Cancer
Novel BRAF Inhibitor Yields Dramatic Responses in Metastatic Melanoma
Novel Agent Motesanib (AMG-706) Active in Recurrent or Metastatic Breast Cancer
Interview with Dr Peter Kaufman on Motesanib for Breast Cancer (Podcast)
Weight-adjusted Dosing of Dalteparin Prevents VTE in Advanced Pancreatic Cancer
Pain Increases Risk for Malnutrition and Poor Performance Status in Cancer Patients
BRAF Mutation Analysis has Clinical Value in Stage III Colon Carcinoma
How Do Patients Perceive Oral Oncology Drugs?
Meta-analysis of Cetuximab plus Chemotherapy Confirms Benefit in NSCLC
Aspirin Associated with Lower Incidence of Colon Cancer in Patients with Lynch Syndrome
Does Endocrine Therapy Increase the Risk of Cardiac Events in Men with Prostate Cancer?
Panitumumab Added to FOLFIRI Boosts Survival in Patients with Metastatic Colorectal Cancer and Wild-Type KRAS Mutations
New Multi-kinase Inhibitor, Regorafenib, Shows Strong First-Line Activity in Metastatic Renal Cell Carcinoma
Amgen Reports Solid Trial Results for Denosumab in Breast and Other Solid Tumors
ECCO-ESMO Welcomes Oncology Professionals with Inspiration and Music
Resection in Women with Stage IV Breast Cancer Improves Survival
PI3K Activation Might Predict Trastuzumab Resistance
Two New Blood Tests Improve Early Detection of GI and Colorectal Cancers
Mutations in EGFR Gene Confer Beneficial Response to Oral TKI Gefitinib in NSCLC
Dutasteride Reduces Prostate Cancer Risk in High-Risk Men